08:00 - 09:30
Parallelsitzung I: Basic Science
Saal Salzburg 1 / Erdgeschoss
Vorsitz: Philipp Stiegler, Graz; Nina Worel, Wien
Enhanced In Vitro Functionality of Porcine Hepatocytes Using 3D Culture Techniques
Including Precision-Cut Liver Slices
Jennifer Weber, Graz
Identifying the cellular source of donor-specific antibodies
Moritz Muckenhuber, Wien
Establishing an in vitro model with Precision-Cut Liver Slices with extended viability
for medical research applications
Johannes Attendeder, Graz
Costimulation-independent secretion of IgM DSA by marginal zone B cells
Marlena Buresch, Wien
Influence of ATG on transferred and endogenous regulatory T cells in mice
Anna Marianne Weijler, Wien
Early detection of postoperative infections via continuous temperature monitoring
Lars Schäfer, Graz
Performance of Steatotic Pig Livers during Sub-Normothermic Machine Perfusion
Sabrina Stimmeder, Graz
Serum Proteomics Analysis of Lung Transplant Patients Receiving Different Induction Therapies
Shahrooz Nasrollahi-Shirazi, Wien
Induced pluripotent stem cell derived hepatocyte-like cells to enhance liver
regeneration during normothermic machine perfusion
Julia Hofmann, Innsbruck
08:00 - 09:30
Parallelsitzung II: Lunge
Saal Wolfgangsee / Erdgeschoss
Vorsitz: Alberto Benazzo, Wien; Holger Flick, Graz
Impulsvortrag
Donor/Recipient Size Matching, from Chest X-ray to Artificial Intelligence
Georg Lang, Zürich
Abstracts
Extended 24-Hour EVLP for Human Donor Lungs: Overcoming Electrolyte Imbalances
and Potentially Extending Perfusion Times with Added Hemodiafiltration
Panja Böhm, Wien
Initial experience with remote ECMO implantation as bridge-to-lung transplant or bridge-to-decision
Panja Böhm, Wien
Impulsvortrag
Infectious Lung diseases as indication for lung transplantation: the era after CF
Holger Flick, Graz
Abstracts
The Impact of Preformed Donor-Specific Antibodies on Outcome after Lung Transplantation:
a Retrospective Single-Center Experience
Sophia Auner, Wien
Beyond the Organ: Lung Microbiome Shapes Transplant Indications and Outcomes
Florian Ponholzer, Innsbruck
08:00 - 09:30
Parallelsitzung III (interprofessionell): Psychologie
Saal Attersee / Erdgeschoss
Vorsitz: Jolana Wagner-Skacel, Graz; Bettina Gober, Wien
Non-adhärenz nach Nierentransplantation - Wie zu erkennen?
Frederik Haupenthal, Wien
Adhärenzfördernde Patient:innenedukation nach einer Nierentransplantation
Brigitte Zinner-Wanggo, Wien
Mom needs a transplant: the psycho-social impact on a family
Esther Scheide, Amsterdam
Die TransplanTiere - der Film
Marion Floquet, Wien
09:30 - 10:00
Kaffeepause & Besuch der Ausstellung
Saal Salzburg 2 / Erdgeschoss
10:00 - 11:30
Plenum 2 (interprofessionell): Wege aus dem Organmangel
Saal Salzburg 1 / Erdgeschoss
Vorsitz: Gabriela Berlakovich, Wien; Gerald Brandacher, Innsbruck
Potential der Maschinenperfusion
Georg Lurje, Heidelberg
Subzero Organ Preservation - Taking Time Out of the Equation
Gerald Brandacher, Innsbruck
Hard to Place Organs und Möglichkeiten, diese zu vermitteln
Stefan Schneeberger, Innsbruck
NRP in Österreich
Benno Cardini / Stephan Eschertzhuber, Innsbruck
Optimierte Nutzung von DCD Organen
Philipp Dutkowski, Zürich
11:45 - 13:45
Lunchtime Sitzung: Comprehensive LifePort Training: Theory and hands-on
(organisiert von Organ Recovery)
Raum Pinzgau / 1. Obergeschoss
Voranmeldung notwendig: https://forms.office.com/r/heBvKfKkpr
This session will provide an in-depth understanding of LifePort Kidney Transporter,
starting with a theoretical overview of the device and followed by a hands-on
cannulation session. Designed to master the LifePort’s application in clinical practice.
11:45 - 12:45
Lunchtime Sitzung: Runder Tisch: Desensibilisierungstherapie von HS-Patienten vor NTx
(organisiert von Hansa Biopharma)
Raum Tennengau / 1. Stock
Vorsitz: Rainer Oberbauer, Wien
Patientenpopulationen, für die eine Desensibilisierung mit Imlifidase in Frage kommt
Rainer Oberbauer, Wien
Protokoll der NTx mit Imlifidase Desensibilisierung
(Prozess vom Delisting über Allokation und Imlifidase-XM-Konversion zur Transplantation)
Kathrin Eller, Graz
Delisting-Strategien, wissenschaftliche und operative Aspekte
Farsad Eskandary, Wien
11:45 - 12:45
2 Parallel Poster Walks
Foyer / Erdgeschoss
Poster Walk 1: Moderatoren: Rupert Oberhuber, Innsbruck; Christian Margreiter, Graz
#01 IONA – Interdisciplinary Oncological Follow-Up Clinic in Vienna,
updated results after 4 years of experience
Sabine Burger, Wien
#03 Non-Alcoholic Steatohepatitis Pig Model for Transplantation Research
Sabrina Stimmeder, Graz
#04 Multimodal Photoacoustic and Ultrasound Imaging System during Ex-vivo Organ Perfusion
Sabrina Stimmeder, Graz
#05 The effect of hemolysis during normothermic machine perfusion of the kidney in RPTEC cells
Julia Hofmann, Innsbruck
#06 Hyperspectral imaging for organ quality assessment of a machine perfused donor liver
Mohamed El-Mahrouk, Graz
#07 Association of inflammatory parameters and complement activity on
Torque Teno virus load in liver transplant patients and healthy volunteers
Markus Wahrmann, Wien
#08 Probiotic intervention to reduce postoperative inflammation in liver transplantation
Judith Kahn, Graz
#09 Liver Transplantation in Metastatic Colorectal Cancer: First case from the Medical University Graz
Christian Margreiter, Graz
#10 Improving adherence to immunosuppression after liver or kidney transplantation
in individuals with impairments in personality functioning –
A randomized controlled single center feasibility study
Jolana Wagner-Skacel & Julia Matzer, Graz
#11 Impact of Extracorporeal Photopheresis on Soluble Factors in Serum of
Lung Transplant Recipients: Preliminary Findings
Panagiotis Parsonidis, Wien
========================================================
Poster Walk 2: Moderatoren: Georg Györi, Wien; Thomas Resch, Innsbruck
#12 Evaluation of the most common microorganisms causing
surgical site infections after renal transplantation
Mohamed El-Mahrouk, Graz
#13 Targeting CD38 in antibody-mediated rejection – The potential of noninvasive
biomarkers to detect rejection reversal and recurrence
Martina Schatzl, Wien
#14 Diaphragmal leak with pleural effusion 1 year after peritoneal dialysis (PD)
Nadina Roth, Linz
#15 Analysis of donor factors in post-mortem kidney transplantation over the years
Andras Deak, Graz
#16 Preoperative evaluation of the iliac calcification score before kidney
transplantation and its impact on postoperative complications
Tim Eichler, Graz (präsentiert durch Judith Kahn, Graz)
#17 Potential impact of Strongyloides stercoralis for future kidney transplant recipients
Daniela Gerges, Wien
#18 Monitoring of medical adherence to immunosuppressive drugs by electronic
healthcare data in kidney transplant recipients – a prospective study
Sebastian Kapps, Wien
#19 Proteinuria in Deceased Kidney Transplant Donors for Prediction of Chronic
Lesions in Pre-Transplant Biopsies – an ongoing prospective multi-center study
Florina Regele, Wien
#20 The impact of immunosuppression on the occurrence of malignancies
after kidney transplantation
Frederick Haupenthal, Wien
#21 Modifiable risk factors for the development of BKPyV-associated complications:
a systematic meta-analysis
Michael Eder, Wien
#22 Early progression of chronic histologic lesions in kidney transplant biopsies
is not associated with HLA histocompatibility
Rhea Jabbour, Wien
13:00 - 14:30
Plenum 3: Jungforscher Preise
Saal Salzburg 1 / Erdgeschoss
Vorsitz: Daniel Cejka, Linz; Kathrin Eller, Graz
KLINISCH
Nor-ursodeoxycholic acid improves biliary markers during normothermic machine perfusion
Jule Dingfelder, Wien
Targeting CD38 in Antibody-Mediated Kidney Transplant Rejection
Katharina Mayer, Wien
Influence of preservation method and contamination during preservation on outcome after liver transplantation
Jule Dingfelder, Wien
Improved Decision Making during Hypothermic Oxygenated Machine Perfusion of
Liver Grafts via Simple Evaluation of Perfusate Electrolytes and Lactate
David Pereyra, Wien
EXPERIMENTELL
Extended preservation of kidneys at subzero temperature using nature-inspired cryoprotectants –
a pilot study in a large animal model
Marlene Pühringer, Innsbruck
Therapeutic application of norUrsodeoxycholic acid in normothermic machine perfusion reduces
perfusate apoptosis markers in livers rejected for transplantation
Laurin Rauter, Wien
Long-Term Tolerance in Heart Allografts Through Selective In-Vivo Expansion of regulatory T cells
Laurenz Wolner, Wien
Enhanced Renal Tissue Regeneration and Functional Recovery with IL-15 Treatment in Acute Kidney Injury
Agnes Mooslechner, Graz
14:30 - 15:00
Kaffeepause & Besuch der Ausstellung
Saal Salzburg 2 / Erdgeschoss
15:00 - 16:30
Parallelsitzung I: Niere 1
Saal Salzburg 1 / Erdgeschoss
Vorsitz: Rainer Oberbauer, Wien; Maria Haller, Linz
Impulsvortrag
Die Bedeutung von NK Zellen in der ABMR
Matthias Diebold, Basel
Abstracts
Spatial Transcriptomics of Glomeruli from Kidney Transplant Biopsies with
Microvascular Inflammation with and without the Presence of DSA
Johannes Kläger, Wien
Long-term Outcome following Pediatric Kidney Transplantation is Similar to Adult Kidney Transplantation
Johannes Schauer, Innsbruck
Establishing a DCD Program in the Region North: First Experiences
Manfred Kalteis, Linz
15:00 - 16:30
Parallelsitzung II: Stammzellen Transplantation 1
Saal Wolfgangsee / Erdgeschoss
Vorsitz: Johannes Clausen, Linz; Nina Worel, Wien
Stepwise implementation of a risk factor-based algorithm for the use and dosage
of anti-T-lymphocyte globulin (ATLG) for the prevention of severe graft-versus-host
disease (GVHD) in a single stem cell transplant center – a retrospective analysis
Johannes Clausen, Linz
Mikrobiom und Zelltherapien: 'Der Tod sitzt im Darm?
Was Sie über Ernährung, Mikrobiom und moderne T Zelltherapien schon immer wissen wollten'
Felix Keil, Wien
ECP: Indikation- Durchführung – Therapieerfolg
Sareban Nazanin, Graz
Ruxolitinib in acute and chronic graft-versus-host disease -
extended follow-up of a named patient use cohort including overlap- and donor lymphocyte induced GvHD
Anna Bauhofer, Linz
Long-term Outcome after Reduced Intensity Conditioning (RIC)- based allogeneic Hematopoietic
Stem Cell Transplantation (HSCT) in pediatric Sickle Cell Disease (SCD)
Natalija Zubarovskaya, Wien
+++++ Drinks & Snacks kindly provided by NEOVII +++++
15:00- 16:30
Parallelsitzung III (interprofessionell): GVHD & Multidisziplinäre Betreuung
Saal Attersee / Erdgeschoss
Vorsitz: Zuzana Steiner, Wien; Anita Lawitschka, Wien
Pflege und Topische Therapien bei GVHD
Zuzana Steiner, Wien
Physiostatus bei GVHD
Simone Gutdeutsch, Wien
Ernährung bei pädiatrischer Darm GVHD
Barbara Lechner, Wien
ePROTECT
Gabriele Kropshofer, Innsbruck
Multidisziplinäre Betreuung in der Langzeitnachsorge durch IONA
Sabine Burger, Wien
EU-CAYAS-NET: The European Network of Youth Cancer Survivors
Hannah Gsell, Wien
+++++ Drinks & Snacks kindly provided by NEOVII +++++
16:45 - 18:15
Plenum 4: Welche Optionen gibt es für hochsensibilisierte Kandidaten für eine Nierentransplantation?
Saal Salzburg 1 / Erdgeschoss
Vorsitz: Rainer Oberbauer, Wien; Farsad Eskandary, Wien
Definition von Sensibilisierung – was sagt das HLA Labor?
Gottfried Fischer, Wien
Welche Antikörper in welcher Höhe sind zu beachten/stellen ein Problem dar
Desensibilisierung – was funktioniert?
Farsad Eskandary, Wien
Imlifidase – Indikationen und was ist die Evidenz/Erfahrung bisher
Rainer Oberbauer, Wien
Erhaltungstherapie nach erfolgreicher Desensibilisierung – was ist gesichert?
Kathrin Eller, Graz
18:15 - 18:45
ATX Generalversammlung
Saal Wolfgangsee / Erdgeschoss
19:30 - 23:00
Award-Dinner & Networking
Stiegl-Keller
VERBINDLICHE Voranmeldung notwendig. No-Show Gebühr (bei Nichterscheinen nach Anmeldung): EUR 50,00 pro Person!
Änderungen vorbehalten!